Evidence map›Paper›PMID 24335996›Full record

ArticleNature communications2013

The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension.

Xue Bai, Kaitlin C Lenhart, Kim E Bird, Alisa A Suen, Mauricio Rojas, Masao Kakoki, Feng Li, Oliver Smithies, Christopher P Mack, Joan M Taylor

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Functional analysis ofFrontiers in cardiovascular medicine · 2025
    Article
  10. Gene editing of angiotensin for blood pressure management.International journal of cardiology. Cardiovascular risk and prevention · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Fixing the GAP: The role of RhoGAPs in cancer.European journal of cell biology · 2022
    Review
  16. Article
  17. Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xue BaiDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Kaitlin C LenhartDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Kim E BirdDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Alisa A SuenDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Mauricio RojasMcAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Masao KakokiDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Feng LiDepartment of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA.
Oliver Smithies1] Department of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA [2] McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Christopher P Mack1] Department of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA [2] McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Joan M Taylor1] Department of Pathology and Lab Medicine, University of North Carolina, 501 Brinkhous-Bullitt Building CB 7525, Chapel Hill, North Carolina 27599, USA [2] McAllister Heart Institute, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
University of North Carolina at Chapel Hill · US

Funding

Genetic and epigenetic regulation of vascular smooth muscle cell phenotype and contractilityR01HL109607 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2012 to 2022
$3.0M
Regulation of Smooth Muscle Differentiation by RhoAR01HL070953 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2002 to 2012
$2.8M
FAK Signaling in cardiac growth and hypertrophyR01HL081844 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2005 to 2013
$2.6M
Smooth muscle adhesion and plasticity in coronary and outflow tract developmentR01HL102446 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2010 to 2013
$1.3M
Adhesion Signaling in Vascular Growth and DevelopmentR01HL071054 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M. · 2003 to 2006
$1.2M
NHLBI NIH HHS HL070953NHLBI NIH HHS HL071054NHLBI NIH HHS HL081844NHLBI NIH HHS HL109607NHLBI NIH HHS R01 HL070953NHLBI NIH HHS R01 HL071054NHLBI NIH HHS R01 HL081844NHLBI NIH HHS R01 HL102446NHLBI NIH HHS R01 HL109607
6 · The paper itself

Abstract

Although hypertension is a worldwide health issue, an incomplete understanding of its aetiology has hindered our ability to treat this complex disease. Here we identify arhgap42 (also known as GRAF3) as a Rho-specific GAP expressed specifically in smooth muscle cells (SMCs) in mice and humans. We show that GRAF3-deficient mice exhibit significant hypertension and increased pressor responses to angiotensin II and endothelin-1; these effects are prevented by treatment with the Rho-kinase inhibitor, Y27632. RhoA activity and myosin light chain phosphorylation are elevated in GRAF3-depleted SMCs in vitro and in vivo, and isolated vessel segments from GRAF3-deficient mice show increased contractility. Taken together, our data indicate that GRAF3-mediated inhibition of RhoA activity in vascular SMCs is necessary for maintaining normal blood pressure homoeostasis. Moreover, these findings provide a potential mechanism for a hypertensive locus recently identified within arhgap42 and provide a foundation for the future development of innovative hypertension therapies.

Indexed as

Amino Acid SequenceAngiotensin IIAnimalsAortaBlood PressureBlood VesselsCells, CulturedFemaleGTPase-Activating ProteinsHumansHypertensionIn Vitro TechniquesMaleMiceMice, Mutant StrainsMolecular Sequence DataAngiotensin IIARHGAP42 protein, humanArhgap42 protein, MouseGTPase-Activating ProteinsMyosin Light ChainsrhoA GTP-Binding Protein

Identifiers

PMID24335996
PMCPMC4237314
OpenAlexW2057216196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.